FBXO44 promotes DNA replication-coupled repetitive element silencing in cancer cells

Shen, Jia Z., Qiu, Zhixin, Wu, Qiulian, Finlay, Darren, Garcia, Guillermina, Sun, Dahui, Rantala, Juha, Barshop, William +7 more·2021·Cell
DOI 10.1016/j.cell.2020.11.042

Cited by (113)

Items 101–113 of 113

  1. Epigenetic Drugs as Modulators of Tumor Immunogenicity and Host Immune Response
    Enrica Marchi, Ipsita Pal, John Sanil Manavalan, Kallesh Danappa Jayappa, Owen A. O’Connor · 2024
  2. KDM5 demethylases suppress R-loop-mediated ‘viral mimicry’ and DNA damage in breast cancer cells
    Lena Lau, Kurt Henderson, Ahu Turkoz, Sara B. Linker, Dörte Schlesinger, Brad T. Townsley, Brian S. Egan, Shoba Ragunathan, Robert A. Rollins, Xianju Bi et al. · 2025 · eLife
  3. KDM5 demethylases suppress R-loop-mediated “viral mimicry” and DNA damage in breast cancer cells
    Lena Lau, Kurt Henderson, Ahu Turkoz, Sara B. Linker, Dörte Schlesinger, Brad T. Townsley, Brian S. Egan, Shoba Ragunathan, Robert A. Rollins, Xianju Bi et al. · 2025 · eLife
  4. KDM5 demethylases suppress R-loop-mediated “viral mimicry” and DNA damage in breast cancer cells
    Lena Lau, Kurt Henderson, Ahu Turkoz, Sara B. Linker, Dörte Schlesinger, Brad T. Townsley, Brian S. Egan, Shoba Ragunathan, Robert A. Rollins, Xianju Bi et al. · 2025 · eLife
  5. Baicalein Inhibits Proliferation, Migration, and Invasion of Mesothelioma Cells Through the p53–FOXM1 Signaling Axis
    Xin-Yi Zheng, Chao Guo, Jie Peng, Pingping Tang, Ze Xia, Wenfei Xu, Xuhui Li · 2025 · Cancer Management and Research
  6. Additional file 6 of MolData, a molecular benchmark for disease and target based machine learning
    Arash Keshavarzi Arshadi, Milad Salem, Arash Firouzbakht, Yuan, Jiann Shiun · 2022 · Figshare
  7. DMAP1 Deficiency Suppresses Lung Cancer Progression by Destabilizing Replication Fork and Activating IFN Signaling‐Mediated Anti‐tumor Immunity
    Kan Huang, Xi Dai, Shuaihu Li, Yingxue Chen, Yaxin Yu, Lin Wang, Kun Liu, SHUHAN LYU, Chongyang Li, Yihua Sun et al. · 2026 · Advanced Science
  8. Detection of nuclear STING in cultured human cells and in the normal and cancer tissues
    Nicolas Vo, Eleanor Y. Chen, Julia M. Sidorova · 2026 · iScience
  9. Pan-cancer multi-omics analysis identifies SYNGR4 as a novel clinical prognostic biomarker and therapeutic target in lung adenocarcinoma
    Yanjiao Hou, Bing Fu, Lifang Zhan, Jun Guan, TIAN Hui · 2026 · Discover Oncology
  10. ZNF263–NuRD-mediated repression of STAT1 curtails MHC-I antigen presentation and IFN-γ efficacy in prostate cancer
    Han Guan, Likai Mao, F Fang, Tiange Wu, Yifei Cheng, Zonghao You, Hao Lin, Ruixin Zhang, J. Zhuang, Gao‐Jun Teng et al. · 2026 · Proceedings of the National Academy of Sciences
  11. The TAF3/SREBP2/cholesterol axis drives tumor progression in hepatocellular carcinoma
    Jialin Qiu, Lei Cao, Yi Li, Yan Li, Zhi-Qi Yin, De-Jun Kong, Na Chen, Zheng-Lu Wang · 2026 · Clinical and Experimental Medicine (Testo stampato)
  12. Context-Dependent cGAS-STING Activation Shapes Metastatic Progression and Dormancy
    Eilma Akter-Yasuoka, 이탁, Takahiko Murayama, Jun Nakayama · 2026 · Cells
  13. Dynamic regulation of H3K9 modifications in cancer: pathogenesis and targeted therapies
    Yuanyuan Xu, Qihui Wu, Yuxiu Zhang, Jitong Zhao, Xiaodan Fu, Anqi Li, Yimin Li · 2026 · Biomarker Research